SCTX (Scribe Therapeutics) Total Tax Payable: $0.07 Mil (As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

SCTX Scribe Therapeutics Inc SCTX
8 GF Score
Price $22.00
View Full Analysis

What is Scribe Therapeutics Total Tax Payable?

Scribe Therapeutics SCTX -13.40% 8 Total Tax Payable is $0.07 Mil as of Mar. 2026. GuruFocus rates SCTX with a GF Score™ of 8/100.

Scribe Therapeutics's Total Tax Payable for the quarter that ended in Mar. 2026 was $0.07 Mil.

Scribe Therapeutics's quarterly Total Tax Payable stayed the same from Mar. 2025 ($0.00 Mil) to Dec. 2025 ($0.00 Mil) but then increased from Dec. 2025 ($0.00 Mil) to Mar. 2026 ($0.07 Mil).

Scribe Therapeutics's annual Total Tax Payable increased from . 20 ($0.00 Mil) to Dec. 2024 ($0.64 Mil) but then declined from Dec. 2024 ($0.64 Mil) to Dec. 2025 ($0.00 Mil).

Scribe Therapeutics Total Tax Payable Related Terms

Scribe Therapeutics Total Tax Payable Historical Data

* Premium members only.

The historical data trend for Scribe Therapeutics's Total Tax Payable can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Scribe Therapeutics Total Tax Payable Chart

Scribe Therapeutics Annual Data
Trend Dec24 Dec25
Total Tax Payable
0.64 0.00

Scribe Therapeutics Quarterly Data
Dec24 Mar25 Dec25 Mar26
Total Tax Payable 0.64 0.00 0.00 0.07
SCTX
8GF Score
Scribe Therapeutics Inc SCTX
Total Tax Payable is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Scribe Therapeutics Total Tax Payable Calculation

Total Tax Payable is the taxes liability owed to federal, state, and local tax authorities. It is the carrying value as of the balance sheet date of obligations incurred and payable for statutory income, sales, use, payroll, excise, real, property and other taxes.

Frequently Asked Questions Learn more about Total Tax Payable →
What does a Total Tax Payable of $0.07 Mil mean?
Scribe Therapeutics (SCTX) has a Total Tax Payable of $0.07 Mil as of Mar. 2026. Tax Payable is the taxes liability owed to federal, state, and local tax authorities. View historical data on Scribe Therapeutics and its competitors.
Is Scribe Therapeutics' Total Tax Payable too high?
Scribe Therapeutics' current Total Tax Payable is $0.07 Mil. Overall, Scribe Therapeutics has a GF Score™ of 8/100, reflecting its overall financial health beyond just this single metric.
How does Scribe Therapeutics' Total Tax Payable compare to ?
Scribe Therapeutics' Total Tax Payable of $0.07 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Total Tax Payable for a Biotechnology company?
A good Total Tax Payable depends on the Biotechnology industry context. However, Total Tax Payable should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Total Tax Payable mean?
A high Total Tax Payable can signal that a stock is expensive relative to its fundamentals. Tax Payable is the taxes liability owed to federal, state, and local tax authorities. View historical data on Scribe Therapeutics and its competitors. Scribe Therapeutics's current Total Tax Payable is $0.07 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Scribe Therapeutics stock overvalued right now?
Scribe Therapeutics (SCTX) has a current Total Tax Payable of $0.07 Mil. The current Total Tax Payable is $0.07 Mil. Scribe Therapeutics' overall GF Score™ is 8/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Total Tax Payable calculated?
Total Tax Payable is calculated from a company's financial statements. For Scribe Therapeutics (SCTX), the current Total Tax Payable is $0.07 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Scribe Therapeutics Business Description

Comparable Companies
Address 1150 Marina Village Parkway, Alameda, CA, USA, 94501
Scribe Therapeutics Inc is a clinical-stage biotechnology company engaged in the development of in vivo CRISPR-based genetic medicines. Its research and development activities focus on cardiovascular and metabolic diseases, including atherosclerotic cardiovascular disease (ASCVD). The company's product pipeline includes STX-1150, a CRISPR-based product candidate that utilizes its ELXR epigenetic silencing technology.
8GF Score

Get the complete analysis for SCTX

Total Tax Payable is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$22.00
Price